Skip to main content
. 2020 Sep 16;11:570721. doi: 10.3389/fphar.2020.570721

Table 7.

Significant findings after multiple regression analyses of covariates with recovery until hospital discharge, stratified by median value.

Overall patients(n = 93). P value. Asthma and allergy patients (n = 21). P value. Other patients(n = 72). P value.
Age 0.002 n.s. 0.013
Comorbidity excluding asthma or allergy 0.015 n.s. n.s.
Antecedents of dyslipidemia n.s. 0.025 n.s.
Antecedents of hypertension n.s. n.s. 0.030
Antecedents of prothrombotic disorders n.s. 0.010 0.050
Drugs used in allergic diseases
Inhaled corticosteroids 0.051 0.033 0.005
Drugs used in cardiovascular diseases
Angiotensin-II-receptor antagonists n.s. 0.043 n.s.
Symptoms
Musculoskeletal pain 0.012 n.s. 0.021
Laboratory and clinical findings
Oxygen saturation 0.007 n.s. 0.006
Leukocytes per microliter n.s n.s 0.034
Eosinophils per microliter 0.006 n.s. n.s.
D-dimer, ng/mL 0.006 n.s. n.s
Ferritin, ng/mL n.s n.s 0.002
Radiological findings
No radiological findings 0.005 n.s. 0.002
Drug therapy after admission
Lopinavir plus ritonavir 0.032 n.s. n.s.
Corticosteroids 0.001 0.033 0.001